What You Should Know
- The Launch: Walgreens has expanded its virtual healthcare platform to include Walgreens Weight Management, a digital clinic connecting eligible adults (18-64) with doctors or nurse practitioners to obtain FDA-approved weight loss medications.
- The Pricing Model: In a direct shot at subscription-heavy telehealth competitors, Walgreens is charging a flat $49 per visit with zero monthly subscription fees.
- The Target Audience: The service is explicitly designed for the “self-pay” market—patients whose employers or insurance plans do not cover GLP-1 medications for weight loss.
- The Drug Costs: Walgreens is leveraging its Rx Savings Finder tool to offer Novo Nordisk’s Wegovy at heavily reduced out-of-pocket prices: starting at $149/month for tablets and $199/month for injectables.
Breaking the Subscription Model
Over the last two years, digital health platforms like Ro, Hims & Hers, and Noom have built massive subscriber bases by offering virtual access to weight loss drugs. However, these platforms typically lock patients into monthly membership fees (often $80 to $150 a month) just to access the provider, completely separate from the cost of the medication itself.
Walgreens is using a pure pay-as-you-go model. For $49, a patient gets an online video visit with a licensed provider who evaluates their medical history and goals. If eligible, the provider prescribes an FDA-approved GLP-1. Follow-up visits for medication adjustments and side effect management are available on-demand, 7 days a week.
Solving the Out-of-Pocket Crisis
Getting the prescription is only half the battle; affording the drug is the real hurdle for self-pay patients. To address this, Walgreens is tightly integrating this virtual clinic with its Rx Savings Finder tool (powered by RxSense).
By keeping the patient in the Walgreens ecosystem, the company is offering Novo Nordisk’s Wegovy (semaglutide) at heavily discounted self-pay rates:
- $149 per month for the newly launched Wegovy 1.5 mg or 4 mg tablets.
- $199 per month for the Wegovy 0.25 mg and 0.5 mg injectables.
“Expanding our virtual healthcare platform to include weight management is part of our ongoing commitment to listening to patients and the services they want from their local pharmacy,” said Rick Gates, Chief Pharmacy Officer, Walgreens. “By combining trusted clinical expertise with the reach of our digital and pharmacy network, we’re helping eligible patients take meaningful steps toward better health, on their own terms.”
Walgreens Weight Management is currently available in 28 states.
